FGFR1 and lung adenocarcinoma: The FGFR1/JNK/Vimentin/Snail signalling cascade emerges as a pivotal pathway governing EMT in lung adenocarcinoma through TMEM176B overexpression, and this suggests that TMEM176B is a potential therapeutic target for lung adenocarcinoma.